API
< Back to all clusters
[HEALTH] · Brazil · 2 sources

started · updated

GLP-1 medications may show potential link to reduced fibromyalgia symptoms

A study published in the journal Rheumatology suggests a potential link between the use of GLP-1 receptor agonists, such as those used for diabetes and obesity, and a reduction in fibromyalgia symptoms like pain and fatigue. The research analyzed data from over 96,000 individuals and noted fewer reports of pain, exhaustion, and opioid use among patients using these medications.

However, researchers and medical experts, including neurosurgeon Marcelo Valadares from Unicamp, emphasize that the study shows an association rather than direct causation. It has not been proven that these medications specifically treat fibromyalgia, and patients should not use them for this purpose without medical guidance.

Entities

Einstein Hospital Israelita · Jama Neurology · Rheumatology · Unicamp